Back to search

Article

Targeting pathogenic Lafora bodies in Lafora disease using an antibody-enzyme fusion

2019-06-21

Abstract excerpt

Lafora disease (LD) is a fatal childhood epilepsy and a non-classical glycogen storage disorder with no effective therapy or cure. LD is caused by recessive mutations in the EPM2A or EPM2B genes that encode the glycogen phosphatase laforin and an E3 ubiquitin ligase malin, respectively. A hallmark of LD is the intracellular accumulation of abnormal and insoluble α-linked polysaccharide deposits known as Lafora b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
96128388-9aac-53ff-9af8-29ecbc8aa269
DOI
10.1101/679407
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting pathogenic Lafora bodies in Lafora disease using an antibody-enzyme fusionDOI 10.1101/679407
Select a neighboring publication to make it the new centre.